Table 2 of Sheereen, Mol Vis 2011; 17:3523-3528.
Controls (n=125) | VKH patients (n=30) | |||||
---|---|---|---|---|---|---|
HLA-C alleles | Alleles (n) | % | Alleles (n) | % | p value | OD 95%(CI) |
cw*01/C1 | 15 | 6 | 2 | 3.3 | ||
cw*02/C2 | 8 | 3.2 | 2 | 3.3 | ||
cw*03/C1 | 10 | 8 | 1 | 1.6 | ||
cw*04/C2 | 26 | 10.4 | 6 | 10 | ||
cw*05/C1 | 1 | 0.4 | 1 | 1.6 | ||
cw*06/C2 | 52 | 20.8 | 19 | 31.6 | ||
cw*07/C1 | 52 | 20.8 | 9 | 15 | ||
cw*08/C1 | 10 | 4 | 1 | 1.6 | ||
cw*12/C1 | 20 | 8 | 1 | 1.6 | ||
cw*14//C1 | 0 | 0 | 2 | 3.3 | 0.037 | 5.3103(4.211–6.696) |
cw*15/C2 | 47 | 18.8 | 4 | 6.7 | 0.0205 | 0.3085 (1.06–0.893) |
cw*1507/C1 | 1 | 0.4 | 0 | 0 | ||
cw*16/C1 | 4 | 1.6 | 0 | 0 | ||
cw*1602/C2 | 2 | 0.8 | 2 | 3.3 | ||
cw*17/C2 | 2 | 0.8 | 9 | 15 | <0.0001 | 21.88 (4.59–104.29) |
cw*18/C2 | 0 | 0 | 1 | 1.6 | ||
Total no of alleles (n) | 250 | 60 |